129 related articles for article (PubMed ID: 34813865)
1. Nanovesicles containing curcumin hold promise in the development of new formulations of anti-Acanthamoebic agents.
Saeed BQ; Hussain K; Akbar N; Khan H; Siddiqui R; Shah RM; Khan NA
Mol Biochem Parasitol; 2022 Jan; 247():111430. PubMed ID: 34813865
[TBL] [Abstract][Full Text] [Related]
2. Cinnamic acid and lactobionic acid based nanoformulations as a potential antiamoebic therapeutics.
Akbar N; Kawish M; Jabri T; Khan NA; Shah MR; Siddiqui R
Exp Parasitol; 2023 Mar; 246():108474. PubMed ID: 36708943
[TBL] [Abstract][Full Text] [Related]
3. Oleic acid-conjugated silver nanoparticles as efficient antiamoebic agent against Acanthamoeba castellanii.
Anwar A; Abdalla SAO; Aslam Z; Shah MR; Siddiqui R; Khan NA
Parasitol Res; 2019 Jul; 118(7):2295-2304. PubMed ID: 31093751
[TBL] [Abstract][Full Text] [Related]
4. Silver nanoparticle conjugation affects antiacanthamoebic activities of amphotericin B, nystatin, and fluconazole.
Anwar A; Siddiqui R; Hussain MA; Ahmed D; Shah MR; Khan NA
Parasitol Res; 2018 Jan; 117(1):265-271. PubMed ID: 29218442
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of nanoparticles with 5-fluorouracil and chloroquine on Acanthamoeba castellanii activity.
Saeed BQ; Qalaji MR; Akbar N; Siddiqui R; Roberta C; Manzoor S; Muhammad JS; Adrees AO; Al-Shahrabi R; Khan NA
Mol Biochem Parasitol; 2022 Jul; 250():111492. PubMed ID: 35714753
[TBL] [Abstract][Full Text] [Related]
6. Metformin-coated silver nanoparticles exhibit anti-acanthamoebic activities against both trophozoite and cyst stages.
Anwar A; Soomaroo A; Anwar A; Siddiqui R; Khan NA
Exp Parasitol; 2020 Aug; 215():107915. PubMed ID: 32461112
[TBL] [Abstract][Full Text] [Related]
7. Anti-amoebic activity of a series of benzofuran/benzothiophene derivatives against Acanthamoeba castellanii belonging to the T4 genotype.
Akbar N; El-Gamal MI; Zaraei SO; Saeed BQ; Khan NA; Siddiqui R
J Appl Microbiol; 2023 Jan; 134(1):. PubMed ID: 36626774
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial activities of green synthesized gums-stabilized nanoparticles loaded with flavonoids.
Anwar A; Masri A; Rao K; Rajendran K; Khan NA; Shah MR; Siddiqui R
Sci Rep; 2019 Feb; 9(1):3122. PubMed ID: 30816269
[TBL] [Abstract][Full Text] [Related]
9. Antiamoebic activity of 3-aryl-6,7-dimethoxyquinazolin-4(3H)-one library against Acanthamoeba castellanii.
Shahbaz MS; Anwar A; Saad SM; Kanwal ; Anwar A; Khan KM; Siddiqui R; Khan NA
Parasitol Res; 2020 Jul; 119(7):2327-2335. PubMed ID: 32476058
[TBL] [Abstract][Full Text] [Related]
10. Antiamoebic activity of synthetic tetrazoles against Acanthamoeba castellanii belonging to T4 genotype and effects of conjugation with silver nanoparticles.
Anwar A; Yi YP; Fatima I; Khan KM; Siddiqui R; Khan NA; Anwar A
Parasitol Res; 2020 Jun; 119(6):1943-1954. PubMed ID: 32385711
[TBL] [Abstract][Full Text] [Related]
11. Repositioning of Guanabenz in Conjugation with Gold and Silver Nanoparticles against Pathogenic Amoebae
Anwar A; Mungroo MR; Anwar A; Sullivan WJ; Khan NA; Siddiqui R
ACS Infect Dis; 2019 Dec; 5(12):2039-2046. PubMed ID: 31612700
[TBL] [Abstract][Full Text] [Related]
12. Potential anti-amoebic activity of sulfonate- and sulfamate-containing carboxamide derivatives against pathogenic Acanthamoeba castellanii belonging to the genotype T4.
Akbar N; Siddiqui R; El-Gamal MI; Zaraei SO; Saeed BQ; Alawfi BS; Khan NA
Parasitol Int; 2024 Feb; 98():102814. PubMed ID: 37806551
[TBL] [Abstract][Full Text] [Related]
13. Gold Nanoparticle Conjugation Enhances the Antiacanthamoebic Effects of Chlorhexidine.
Aqeel Y; Siddiqui R; Anwar A; Shah MR; Khan NA
Antimicrob Agents Chemother; 2015 Dec; 60(3):1283-8. PubMed ID: 26666949
[TBL] [Abstract][Full Text] [Related]
14. Potential anti-acanthamoebic effects through inhibition of CYP51 by novel quinazolinones.
Ahmed U; Ho KY; Simon SE; Saad SM; Ong SK; Anwar A; Tan KO; Sridewi N; Khan KM; Khan NA; Anwar A
Acta Trop; 2022 Jul; 231():106440. PubMed ID: 35378058
[TBL] [Abstract][Full Text] [Related]
15. CONJUGATION WITH SILVER NANOPARTICLES ENHANCES ANTI-ACANTHAMOEBIC ACTIVITY OF KAPPAPHYCUS ALVAREZII.
Walvekar S; Anwar A; Anwar A; Lai NJY; Yow YY; Khalid M; Siddiqui R; Khan NA
J Parasitol; 2021 Jul; 107(4):537-546. PubMed ID: 34265050
[TBL] [Abstract][Full Text] [Related]
16. Clinically Approved Drugs against CNS Diseases as Potential Therapeutic Agents To Target Brain-Eating Amoebae.
Anwar A; Rajendran K; Siddiqui R; Raza Shah M; Khan NA
ACS Chem Neurosci; 2019 Jan; 10(1):658-666. PubMed ID: 30346711
[TBL] [Abstract][Full Text] [Related]
17. Antidiabetic Drugs and Their Nanoconjugates Repurposed as Novel Antimicrobial Agents against Acanthamoeba
Anwar A; Siddiqui R; Raza Shah M; Khan NA
J Microbiol Biotechnol; 2019 May; 29(5):713-720. PubMed ID: 31030451
[No Abstract] [Full Text] [Related]
18. Novel Tetrazoles against Acanthamoeba castellanii Belonging to the T4 Genotype.
Wehelie YI; Khan NA; Fatima I; Anwar A; Kanwal K; Khan KM; Siddiqui R; Tong YK; Anwar A
Chemotherapy; 2022; 67(3):183-192. PubMed ID: 34724675
[TBL] [Abstract][Full Text] [Related]
19. Cobalt nanoparticles as novel nanotherapeutics against Acanthamoeba castellanii.
Anwar A; Numan A; Siddiqui R; Khalid M; Khan NA
Parasit Vectors; 2019 Jun; 12(1):280. PubMed ID: 31159839
[TBL] [Abstract][Full Text] [Related]
20. Anti-Acanthamoebic properties of resveratrol and demethoxycurcumin.
Aqeel Y; Iqbal J; Siddiqui R; Gilani AH; Khan NA
Exp Parasitol; 2012 Dec; 132(4):519-23. PubMed ID: 23010569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
